Australia's Telix Pharmaceuticals announced on September 21, 2026 that it has agreed to acquire German radioisotope supplier ITM Isotope Technologies Munich SE on a transaction with a total value of up to US$2.35 billion.

Australia's Telix Pharmaceuticals announced on September 21, 2026 that it has agreed to acquire German radioisotope supplier ITM Isotope Technologies Munich SE on a transaction with a total value of up to US$2.35 billion.